Evidence map›Paper›PMID 32485944›Full record

ArticleVaccines2020

Biodegradable PLGA-

Kirsty L Wilson, Gregory P Howard, Heather Coatsworth, Rhoel R Dinglasan, Hai-Quan Mao, Magdalena Plebanski

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Vaccines, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kirsty L WilsonSchool of Health and Biomedical Sciences, Royal Melbourne Institute of Technology (RMIT) University, Melbourne, VIC 3084, Australia.
Gregory P HowardDepartment of Biomedical Engineering, Johns Hopkins School of Medicine, Baltimore MD 21205, USA.ORCID 0000-0001-5800-3712
Heather CoatsworthEmerging Pathogens Institute, Department of Infectious Diseases & Immunology, College of Veterinary Medicine, University of Florida, Gainesville, FL 32611, USA.
Rhoel R DinglasanEmerging Pathogens Institute, Department of Infectious Diseases & Immunology, College of Veterinary Medicine, University of Florida, Gainesville, FL 32611, USA.ORCID 0000-0001-5433-8179
Hai-Quan MaoDepartment of Biomedical Engineering, Johns Hopkins School of Medicine, Baltimore MD 21205, USA.
Magdalena PlebanskiSchool of Health and Biomedical Sciences, Royal Melbourne Institute of Technology (RMIT) University, Melbourne, VIC 3084, Australia.ORCID 0000-0001-6889-3667

Funding

Nanoparticle Delivery of DNA Vaccine Against Zika VirusR21AI133533 · NIAID · JOHNS HOPKINS UNIVERSITY · PI MAO, HAI-QUAN · 2017 to 2018
$450k
National Science Foundation DGE174891NIH HHS R01AI144609NIH HHS R21AI133533
6 · The paper itself

Abstract

Sustained immune responses, particularly antibody responses, are key for protection against many endemic infectious diseases. Antibody responses are often accompanied by T helper (Th) cell immunity. Herein we study small biodegradable poly (ethylene glycol)-

Indexed as

adjuvantantibodyimmune responsenanoparticlevaccine

Identifiers

PMID32485944
PMCPMC7349924

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.